Publication | Closed Access

Evaluation of the in vitro activity of WCK 5222 (cefepime/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: Expanding the zone of hope

MedicineKlebsiella PneumoniaeAntibacterial AgentMicrobiologyWck 5222PharmacologyClinical MicrobiologyAntimicrobial ResistanceAvailable Combination TherapiesVitro Activity